What's New in Health Care Reform: Feb. 20 - Insights
Top highlights include: Flu shot kept about 50% from going to doctor, racial disparities in cancer incidence and survival rates are narrowing, having anesthesia once as a baby does not cause learning disabilities, personalized diet predicts...
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...
Research Roundup Archives - Page 2 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 4 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
December 2023 - Neuropathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Neuropathology.
December 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
Research Archives - Page 2 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
September 2023 - Cytopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cytopathology.
Staffing to Workload: Direct Effort - Insights
Mike Baisch, Systems Engineer at Mayo Clinic, discusses the mechanics of performing a staffing-to-workload analysis in the testing laboratories. There are three primary areas of focus with staffing needs: direct effort, indirect effort, and...
Staffing to Workload: Operational Needs - Insights
Mike Baisch, Systems Engineer at Mayo Clinic, discusses the mechanics of performing a staffing-to-workload analysis in the testing laboratories. There are three primary areas of focus with staffing needs: direct effort, indirect effort, and...
Mayo Clinic Labs @Work: Dr. Vanda Lennon - Insights
A pioneering researcher, Dr. Vanda Lennon has spent five decades delving into questions of neuroimmunology. Today, she continues that work as director of the Neuroimmunology Research Laboratory in Mayo Clinic’s Department of Laboratory...
November 2023 - Gastroenterology Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
May 2023 - Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
Eye Injury Prevention Month - Insights
According to the American Academy of Ophthalmology, it's important to make eye health part of a daily work wellness routine. So what does this mean to those of us working in clinical diagnostic laboratories? For National Eye Injury...
Dangerous Goods Training - Insights
Self-paced online training and certification for safe collection, handling, packaging, and shipment of specimens.
The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...
The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...
Patient-focused pragmatism: The Mayo Clinic innovation model - Insights
In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...
COVID-19: The pandemic that's forever changed laboratory testing - Insights
Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by...
December 2022 - Pulmonary - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.
December 2022 - Bone and Soft Tissue - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Bone and Soft Tissue Pathology.
Learn how our renal genetic testing was developed by a team of experts and is among the most comprehensive diagnostic testing available.
Biopharma only testing - Insights
Find out how our suite of BioPharma Diagnostics-specific neurology testing can provide answers for your patients.
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
Precision oncology therapeutics - Insights
Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.
Mayo Clinic Laboratories offers a robust menu of biomarker testing to assess liver disease related to nonalcoholic and alcoholic causes. These include FibroTest-ActiTest, a first-line screening assay that uses two diagnostic scores based on...
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
New tests launched in January - Insights
In January 2022, Mayo Clinic Laboratories announced twenty five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Demyelinating disease - Insights
Learn about our demyelinating disease testing, including multiple sclerosis, AQP4/MOG-associated disorders, and spinal cord disorders.
Coagulation Disorders - Mayo Clinic Laboratories
Our special coagulation laboratory has been at the forefront of patient-centered and value-based diagnostic laboratory testing, research, and patient management for nearly 90 years.
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...
MCL @Work: Becca Johnson - Insights
Becca Johnson, a dedicated project manager, joined Mayo Clinic in 2014, driven by a desire to contribute to an organization making a global impact. With BioPharma Diagnostics, Becca oversees large projects, ensuring efficient sample...
Mayo Clinic Labs @Work: Katie Perry - Insights
Katie Perry’s work as a supervisor for the Mayo Lab Inquiry call center helps ensure that clients get the information they need, when they need it, and smooths the way for tests to be completed without delay.
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Learn about how our testing for patients with renal, bladder, and prostate cancer identifies the cancer’s genetic traits and helps direct treatment.
Pathology Services - Mayo Clinic Laboratories
The consultative practice at Mayo Clinic Laboratories excels at delivering high quality diagnostic pathology through second-opinion consultations, a robust menu of subspecialty testing and staining, and digital pathology services.
New tests launched in June - Insights
In June 2023, Mayo Clinic Laboratories announced 28 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in May - Insights
In May 2023, Mayo Clinic Laboratories announced 22 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Live and recorded presentations featuring Q&A with subject matter experts who share lessons learned, reflect on current applications for testing, project the future of lab medicine, and provide resources for growing your laboratory.
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
How the COVID-19 pandemic has increased public knowledge of lab testing - Insights
While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
laboratory_approach_to_the_diagnosis_of_amyloidosis.pdf
04/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Amyloidosis: Laboratory Approach to Diagnosis Possible patient presentations: ■ Nephrotic-range proteinuria with or without renal insufficiency...
BioPharma Diagnostics - Insights
BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...